Merck’s Post

Clinical research and trials must be inclusive. By amplifying the experiences of diverse participants, we strive to transform the landscape of clinical research. #Inclusivity #InclusiveClinicalResearch #GlobalContractResearchOrganization #PharmaceuticalResearch #Biotech

The agenda for the Fierce Biotech Summit is LIVE! Get ready to dive into comprehensive tracks on Early-Stage Development, PR & Communications, Preclinical & CMC, and Strategy & Dealmaking. Stay tuned as we share more in-depth information on these sessions in the upcoming weeks. 👉 Check out the full agenda and start planning your summit experience today: https://lnkd.in/gZiJ8nHE Stay updated on all our events by following Fierce Life Sciences Events #FierceBiotechSummit #BiotechInnovation #Networking #Biotech2024 #WeAreFierce #FierceBiotech #FiercePharma #BiotechPR #BiotechEvents

"We should no longer force yesterday’s one-size-fits-all approach onto #biotech’s third wave of advanced drug development. As #precisionmedicine effectively makes every trial today a #raredisease trial, the operations of these trials must keep pace or else we squander today’s most promising clinical advancements. By embracing #AI-optimized approaches, we can improve operations and ensure that decades of scientific #innovation achieve the ultimate goal: improving the human condition." - Rohit Nambisan, Lokavant Article: 'The future is now: Clinical trials must keep up in the age of precision medicine' https://lnkd.in/g5VTskDP via ACRP - Association of Clinical Research Professionals #biohealth #clinicalresearch #technology

Advancing Drug Discovery: The Future is Here! As we continue to push the boundaries of #DrugDiscovery, the need for innovation, collaboration, and cutting-edge science has never been greater. At the heart of this industry is the drive to make a real impact on patients' lives, and I'm proud to be a part of that mission. 🙌 With the 22nd BioPharma Drug Discovery Nexus event on the horizon, I’m excited to connect with leading minds and trailblazers in the field. This event promises to be a game-changer, showcasing breakthroughs in #HitGeneration, #LeadOptimization, and beyond. 🚀 Whether you're a #Biotech enthusiast, #Pharma veteran, or a fellow #Research professional, let’s come together to explore the latest advancements, share insights, and pave the way for the next wave of therapeutics. 💡 Let’s discuss how we can bring the future of medicine to life. If you're attending the event or just passionate about driving #Innovation in this space, I'd love to connect and chat! 🤝 #DrugDiscovery2025 #LifeSciences #BioPharma #Innovation #EventManager #DrugDevelopment #FutureOfMedicine #nexusconference

The 𝟵𝘁𝗵 𝗠𝗶𝗰𝗿𝗼𝗯𝗶𝗼𝗺𝗲 𝗠𝗼𝘃𝗲𝗺𝗲𝗻𝘁 𝗦𝘂𝗺𝗺𝗶𝘁 𝗘𝘂𝗿𝗼𝗽𝗲 is back and more impactful than ever!   What makes this event a MUST?   With first LPB approvals on the horizon and financial pressures tightening, this event will give you a chance to 𝗮𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗲 𝘆𝗼𝘂𝗿 𝗥&𝗗 and 𝘀𝗲𝗰𝘂𝗿𝗲 𝗮 𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗽𝗼𝘀𝗶𝘁𝗶𝗼𝗻 in this rapidly evolving market.   📄𝗚𝗿𝗮𝗯 𝘆𝗼𝘂𝗿 𝗰𝗼𝗽𝘆 𝗼𝗳 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗴𝗲𝗻𝗱𝗮 - https://ter.li/2s1of8   𝗛𝗲𝗿𝗲'𝘀 𝘄𝗵𝗮𝘁'𝘀 𝗡𝗘𝗪 𝗶𝗻 𝟮𝟬𝟮𝟱: 🔷Get closer to clinical readouts with Seres Therapeutics, MRM Health, and Exeliom Biosciences 🔷Navigate paths to clinical readiness with BioGaia Pharma and 𝗟𝘂𝗰𝗮 𝗕𝗶𝗼 🔷Explore cutting-edge analytics and emerging modalities with Prokarium and Intrinsic Medicine, Inc.   📘View the full brochure now - https://ter.li/2s1of8   #MicrobiomeMovementSummitEurope

Overcoming Obstacles and Seizing Opportunities in Early Phase Biotech Research. Access your free roundtable report now: https://ow.ly/kPSe50ShYcR. In this report in partnership with ICON plc, discover insights from leading biotechs on: • Different challenges of each development stage • CRO selection criteria and scoring tools • Additional CRO value vs. traditional value proposition #BiotechResearch #EarlyPhaseBiotech #RoundtableReport #BiotechInsights #ClinicalResearch #PharmaDevelopment

This must-read from Nature Review Drug Discovery breaks down the industrywide R&D spending in 2021, a landmark year in life sciences, with an estimated over $276B—six times the NIH budget and far surpassing the usual $100B figure from PhRMA surveys. Public commercial-stage firms led with 74% of total R&D spending, while private and development-stage companies also played significant roles. R&D intensity was 27% globally and 34% in the US—staggering numbers compared to other industries. This insightful paper highlights the immense investment and innovation driving the industry. #DrugDiscovery #RnDSpending #Pharma https://lnkd.in/gk6xWmFV

🌟 Exciting Update Alert! 🌟 🔬 Get ready to explore the cutting-edge world of biotherapeutics and biosimilars with our latest review article titled "WHO Standards for Biotherapeutics: Evaluating Complex Biological Products," authored by the esteemed experts Ivana Knezevic and Elwyn Griffiths. 📚 This illuminating article delves into the intricate regulatory processes governing biotherapeutic products, offering insights into the evolving landscape of biosimilars evaluation. From the essential role of the World Health Organization to the scientific challenges posed by biosimilars, this article promises to be a thought-provoking read for professionals and enthusiasts alike. 🌍 Let's come together to celebrate the collaboration and expertise behind this groundbreaking article, and stay tuned for its release as we prepare to unravel the complexities of biotherapeutics regulation! #Biotherapeutics #Biosimilars #RegulatoryStandards #WHO #Science #Innovation #StayTuned 🚀

Building a successful company in the biotech industry requires more than an innovative product that fills an unmet need in the market. It also requires dynamic leadership and an unyielding commitment to success. As the CEO of CytoAgents, Teresa Whalen, RPh leads a team of world-renowned clinical drug development experts and scientific advisory board members who are at the forefront of groundbreaking treatment of life-threatening symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation. Learn more about Teresa and the CytoAgents team here: https://lnkd.in/g7P29x3i #biotech #biotechleadership #biotechnology #cytokinereleasesyndrome #crs

Overcoming Obstacles and Seizing Opportunities in Early Phase Biotech Research. Access your free roundtable report now: https://ow.ly/sWik50ShXBQ. In this report in partnership with ICON plc, discover insights from leading biotechs on: • Different challenges of each development stage • CRO selection criteria and scoring tools • Additional CRO value vs. traditional value proposition #BiotechResearch #EarlyPhaseBiotech #RoundtableReport #BiotechInsights #ClinicalResearch #PharmaDevelopment